TG Therapeutics Inc (NASDAQ:TGTX)

13.75
Delayed Data
As of May 24
 0.00 / 0.00%
Today’s Change
7.25
Today|||52-Week Range
17.35
+67.68%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2014

2015

2016

2017
Operating ActivitiesNet Income / Starting Line-55.8M-62.9M-78.3M-118.5M
 
 
 
 
 
Depreciation3.9K15.5K63.0K82.4K
 
 
 
 
 
Total Other Cash Flow26.8M16.2M7.8M16.1M
 
 
 
 
 
Funds From Operations-29.0M-46.8M-70.4M-102.3M
 
 
 
 
 
Funds From/For Other Operating Expenses6.0M-2.1M-8.8M-8.6M
 
 
 
 
 
Net Cash Flow - Operating Activities-35.1M-44.7M-61.6M-93.8M
 
 
 
 
 
 
InvestingIncrease In Investments-18.3M-49.0M-15.2M-28.0M
 
 
 
 
 
Decrease In Investments0.0024.4M42.1M19.8M
 
 
 
 
Capital Expenditures-18.6K-42.2K-344.0K-2.2K
 
 
 
 
 
Net Cash Flow Investing-18.4M-24.7M26.5M-8.2M
 
 
 
 
 
 
FinancingShort Term Borrowings-677.8K0.000.00--
 
 
Long Term Borrowings-52.0K0.00-13.5K0.00
 
 
 
Long Term Debt Reduction0.000.000.000.00--
Net Proceeds Stock Sale69.4M68.8M5.0M133.7M
 
 
 
 
 
Common Preferred Redeemed0.000.000.000.00--
Common Dividends0.000.000.000.00--
Cash Dividends Paid - Total0.000.000.000.00--
Other Sources - Financing0.00--0.000.00--
Other Uses - Financing0.00104.2K0.000.00
 
 
Net Cash Flow - Financing68.6M68.7M5.0M133.7M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash0.00--------
 
Net Change In Cash15.2M-648.3K-30.0M31.7M